Clinical Trial Update: Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the immunogenicity and safety of pediatric vaccines administered with Menactra in healthy toddlers, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Meningococcal Meningitis
• Mumps
• Rubella
• Varicella

Drugs mentioned

• M-M-R II (Measles, Mumps, and Rubella Vaccine)
• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))
• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Meningitis, Measles | Phase 3 | Status: COMPLETED | Results posted: 2011-06-02